|
Status |
Public on May 27, 2021 |
Title |
CD34 shLUC control Rep 1 |
Sample type |
SRA |
|
|
Source name |
human cord blood CD34+ cells_control
|
Organism |
Homo sapiens |
Characteristics |
cell type: CD34+ haematopoietic stem and progenitor cells (HSPCs) treatment: control
|
Treatment protocol |
Control shRNA targetting luciferase or treatment shRNA targetting ERG
|
Growth protocol |
Human cord blood CD34+ cells pooled from multiple donors and lentivirally transduced as previously described (Unnikrishnan et al NAR 44:10644 2016)
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA extracted using miRNeasy kit (Qiagen)
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 4000 |
|
|
Description |
CD34_shLUC_Exp1
|
Data processing |
Alignment to hg19 genome with TopHat2 (standard paramters) Differential expression analysis using DeSeq2 with standard parameters and paired sample information included as a regression variable. Calculation was performed with shLUC as the treated and shERG as the untreated sample. Genome_build: hg19 Supplementary_files_format_and_content: text files containing normalized read counts and DeSeq2 output
|
|
|
Submission date |
Sep 30, 2020 |
Last update date |
May 27, 2021 |
Contact name |
Julie Thoms |
E-mail(s) |
j.thoms@unsw.edu.au
|
Organization name |
UNSW Sydney
|
Department |
Adult Cancer Program
|
Street address |
Level 2, C25 Lowy Cancer Research Centre, UNSW Sydney, High St
|
City |
Randwick |
State/province |
NSW |
ZIP/Postal code |
2052 |
Country |
Australia |
|
|
Platform ID |
GPL20301 |
Series (2) |
GSE158795 |
Disruption of a GATA2, TAL1, ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells [RNA-seq] |
GSE158797 |
Disruption of a GATA2, TAL1, ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells |
|
Relations |
BioSample |
SAMN16302790 |
SRA |
SRX9218987 |